Cargando…

Detection of Mycoplasma pneumoniae in Mexican children with community-acquired pneumonia: experience in a tertiary care hospital

Purpose: Mycoplasma pneumoniae is an important cause of community-acquired pneumonia (CAP). Information on the prevalence of M. pneumoniae in pediatric patients with CAP in Mexico is limited. The aim of this study was to detect M. pneumoniae in hospitalized pediatric patients with CAP. Patients and...

Descripción completa

Detalles Bibliográficos
Autores principales: Merida-Vieyra, Jocelin, Aquino-Andrade, Alejandra, Palacios-Reyes, Deborah, Murata, Chiharu, Ribas-Aparicio, Rosa Maria, De Colsa Ranero, Agustin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503500/
https://www.ncbi.nlm.nih.gov/pubmed/31118700
http://dx.doi.org/10.2147/IDR.S193076
_version_ 1783416425820454912
author Merida-Vieyra, Jocelin
Aquino-Andrade, Alejandra
Palacios-Reyes, Deborah
Murata, Chiharu
Ribas-Aparicio, Rosa Maria
De Colsa Ranero, Agustin
author_facet Merida-Vieyra, Jocelin
Aquino-Andrade, Alejandra
Palacios-Reyes, Deborah
Murata, Chiharu
Ribas-Aparicio, Rosa Maria
De Colsa Ranero, Agustin
author_sort Merida-Vieyra, Jocelin
collection PubMed
description Purpose: Mycoplasma pneumoniae is an important cause of community-acquired pneumonia (CAP). Information on the prevalence of M. pneumoniae in pediatric patients with CAP in Mexico is limited. The aim of this study was to detect M. pneumoniae in hospitalized pediatric patients with CAP. Patients and methods: We performed a descriptive study in a tertiary-level pediatric reference center, obtaining 154 respiratory samples from patients under 18 years of age and diagnosed with CAP. M. pneumoniae was detected by real-time polymerase chain reaction (PCR) targeting the p1 and CARDS genes. Complete blood cell count, measurement of C-reactive protein and detection of IgM and IgG anti-P1 were performed. Clinical, epidemiological and radiological data of the patients were analyzed. Results: M. pneumoniae was detected by real-time PCR in 26.6% of the samples. 39% of the cases occurred during the spring season. A total of 83% of the patients with M. pneumoniae had some underlying disease; renal disease, autoimmune disease and primary immunodeficiencies had a significant association with M. pneumoniae CAP. Children under 6 years of age represented 53.7% of the cases. Fever and cough were the most frequent symptoms. IgM and IgG were positive in 1.9% and 14% of the patients, respectively. In the chest X-ray, 17.1% of the patients showed multifocal alveolar infiltrates pattern. The complications in this series were 26.8%. The mortality in this study was 4.9%. Conclusion: This is the first report in Mexico about M. pneumoniae as a causal agent of CAP in a tertiary care pediatric hospital using real-time PCR and serology. M. pneumoniae was responsible for 26.6% of the cases and was frequent in children under 6 years of age. In addition, we described the clinical presentation in patients with underlying diseases.
format Online
Article
Text
id pubmed-6503500
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-65035002019-05-22 Detection of Mycoplasma pneumoniae in Mexican children with community-acquired pneumonia: experience in a tertiary care hospital Merida-Vieyra, Jocelin Aquino-Andrade, Alejandra Palacios-Reyes, Deborah Murata, Chiharu Ribas-Aparicio, Rosa Maria De Colsa Ranero, Agustin Infect Drug Resist Original Research Purpose: Mycoplasma pneumoniae is an important cause of community-acquired pneumonia (CAP). Information on the prevalence of M. pneumoniae in pediatric patients with CAP in Mexico is limited. The aim of this study was to detect M. pneumoniae in hospitalized pediatric patients with CAP. Patients and methods: We performed a descriptive study in a tertiary-level pediatric reference center, obtaining 154 respiratory samples from patients under 18 years of age and diagnosed with CAP. M. pneumoniae was detected by real-time polymerase chain reaction (PCR) targeting the p1 and CARDS genes. Complete blood cell count, measurement of C-reactive protein and detection of IgM and IgG anti-P1 were performed. Clinical, epidemiological and radiological data of the patients were analyzed. Results: M. pneumoniae was detected by real-time PCR in 26.6% of the samples. 39% of the cases occurred during the spring season. A total of 83% of the patients with M. pneumoniae had some underlying disease; renal disease, autoimmune disease and primary immunodeficiencies had a significant association with M. pneumoniae CAP. Children under 6 years of age represented 53.7% of the cases. Fever and cough were the most frequent symptoms. IgM and IgG were positive in 1.9% and 14% of the patients, respectively. In the chest X-ray, 17.1% of the patients showed multifocal alveolar infiltrates pattern. The complications in this series were 26.8%. The mortality in this study was 4.9%. Conclusion: This is the first report in Mexico about M. pneumoniae as a causal agent of CAP in a tertiary care pediatric hospital using real-time PCR and serology. M. pneumoniae was responsible for 26.6% of the cases and was frequent in children under 6 years of age. In addition, we described the clinical presentation in patients with underlying diseases. Dove 2019-04-18 /pmc/articles/PMC6503500/ /pubmed/31118700 http://dx.doi.org/10.2147/IDR.S193076 Text en © 2019 Merida-Vieyra et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Merida-Vieyra, Jocelin
Aquino-Andrade, Alejandra
Palacios-Reyes, Deborah
Murata, Chiharu
Ribas-Aparicio, Rosa Maria
De Colsa Ranero, Agustin
Detection of Mycoplasma pneumoniae in Mexican children with community-acquired pneumonia: experience in a tertiary care hospital
title Detection of Mycoplasma pneumoniae in Mexican children with community-acquired pneumonia: experience in a tertiary care hospital
title_full Detection of Mycoplasma pneumoniae in Mexican children with community-acquired pneumonia: experience in a tertiary care hospital
title_fullStr Detection of Mycoplasma pneumoniae in Mexican children with community-acquired pneumonia: experience in a tertiary care hospital
title_full_unstemmed Detection of Mycoplasma pneumoniae in Mexican children with community-acquired pneumonia: experience in a tertiary care hospital
title_short Detection of Mycoplasma pneumoniae in Mexican children with community-acquired pneumonia: experience in a tertiary care hospital
title_sort detection of mycoplasma pneumoniae in mexican children with community-acquired pneumonia: experience in a tertiary care hospital
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503500/
https://www.ncbi.nlm.nih.gov/pubmed/31118700
http://dx.doi.org/10.2147/IDR.S193076
work_keys_str_mv AT meridavieyrajocelin detectionofmycoplasmapneumoniaeinmexicanchildrenwithcommunityacquiredpneumoniaexperienceinatertiarycarehospital
AT aquinoandradealejandra detectionofmycoplasmapneumoniaeinmexicanchildrenwithcommunityacquiredpneumoniaexperienceinatertiarycarehospital
AT palaciosreyesdeborah detectionofmycoplasmapneumoniaeinmexicanchildrenwithcommunityacquiredpneumoniaexperienceinatertiarycarehospital
AT muratachiharu detectionofmycoplasmapneumoniaeinmexicanchildrenwithcommunityacquiredpneumoniaexperienceinatertiarycarehospital
AT ribasapariciorosamaria detectionofmycoplasmapneumoniaeinmexicanchildrenwithcommunityacquiredpneumoniaexperienceinatertiarycarehospital
AT decolsaraneroagustin detectionofmycoplasmapneumoniaeinmexicanchildrenwithcommunityacquiredpneumoniaexperienceinatertiarycarehospital